knee implant growth
sale upsid strong finish impress
growth share gain acceler total robot approach
beat expect knee implant growth wide margin vs
cse market grow estim assum snn deliv
project quarter syk growth would equat bp share gain
vs cse half ortho market report appear
knee market grew faster expect ww vs estim
includ upsid perform roughli flat y/i vs cse
improv syk share gain acceler
exceed gain sinc launch mako robot surgeri system
reiter outperform rate
new robot acceler beat estim system
place new robot vs cse estim
robot japan ou placement increas vs cse
term util pull-thru mako procedur total grew
mako total knee grew hip front mako tha
procedur grew impress
organ growth vs cse ep vs report sale
bil impact wors expect fx vs flat estim
strength underli ortho growth org vs cse partial off-set
neuro/spin org vs cse medsurg roughli line org
guidanc in-lin org growth guidanc ep
in-lin estim con ep cse
chang model weve rais estim project
organ sale growth ep valuat tp
base ev/ebitda multipl project ebitda bil
bil risk acquisit integr product delay failur meet lt goal chang
robot surgeri market litigation/regulatory/qu issu
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
stryker corp global manufactur provid medic devic
equip treatment musculoskelet spinal disord
trauma neurosurgeri endoscopi gener surgeri patient care
one-year valuat scenario base
ev/ebitda ebitda
scenario base high-growth segment grow
growth grow
one-year valuat grey scenario base
ev/ebitda grey ebitda grey
scenario base high-growth segment grow
growth grow
 close
addit detail takeaway
figur result half ww ortho market report track share gain us knee
us knee implant growth adjust estim mil robot sale report compani knee sale line syk robot system sale report ortho
sale organ driven strong dd knee perform on-going
mako adopt print implant knee strong cc mil
hip mil
knee mil mil y/i cc vs cse us
knee sale mil mil increas ou knee sale
hip mil mil y/i cc vs cse us hip sale
mil mil increas ou hip sale mil mil
trauma extrem mil mil y/i cc vs cse
us trauma extrem sale mil mil increas
ou trauma extrem sale mil mil increas cc
mil mil y/i cc vs cse us
sale mil mil increas ou sale mil
mako place robot ww robot estim vs robot
us compani place robot quarter vs last year
ww basi compani robot instal y/i
 y/i januari compani receiv japanes approv
mako partial knee indic robot japan mako
procedur total grew nearli bring full year total
mako total knee procedur grew
year
sale report organ endoscopi report dd growth
instrument mil mil y/i cc vs cse us
instrument sale mil mil increas ou instrument sale
mil mil increas cc instrument sale growth driven
gain wast manag smoke evacu
endoscopi mil mil y/i cc vs cse us
endoscopi sale mil mil increas ou endoscopi sale
mil mil decreas cc endoscopi double-digit growth
video includ camera accessori suction irrig boom
well light busi
medic mil mil y/i cc vs cse us
medic sale mil mil increas ou medic sale
mil mil increas cc due strong perform perform bed
sustain mil mil y/i cc vs cse
us sustain sale mil mil increas
sale organ driven strong demand neurotech product
along demand europ emerg market
neurotech mil mil y/i cc vs cse
us neurotech sale mil mil increas ou neurotech
sale mil mil increas cc reflect strength hemorrhag
ischem stroke product
spine mil mil y/i cc vs cse us
spine sale mil mil increas ou spine sale mil
mil increas cc manag comment much
integr behind compani expect improv growth go
 op margin bp estimate bp y/i
bottom line sale net cog higher tax off-set lower
non-op incom deliv ep estim gross
margin bp estim bp last year
quarter gm favor impact fx partial off-set price mix
compani expect organ sale growth rang manag
expect ep guidanc compani expect fx nomin impact
compani expect ep extra sell day vs
last year quarter number sell day
estimate bpop bpnon-op bpnet chg y/i charl martineau univers toronto januari
salesy/i chg cc cg org cg salesy/i chg cc cg org estimate varianc charl martineau univers toronto januari
chang model
weve rais sale estim slightli project organ growth in-
line manag guidanc weve rais ep
rais ep estim follow three year
figur chang model
compani mention price
matt miksic vik chopra certifi respect compani secur individu analyz view express
report accur reflect person view subject compani secur part
compens directli indirectli relat specif recommend view express report
